Computational Pathology – The Next Revolution in Cancer Diagnostics for Drug Development
Time: 9:00 am
day: Day One
Details:
- Computational Pathology provides greater analytical precision and potentially greater clinical accuracy enabling identification of best patients populations for clinical response to oncology therapies
- Quantitative Continuous Scoring (QCS) was developed to both quantify target expression in individual tumour cells and to quantify spatial heterogeneity of expression
- We will discuss how we are leveraging Computational Pathology approaches in drug development and our vision for Computational Pathology in drug development
